Formulated tPA-releasing PLGA NPs for slow lysis of fibrin-rich clots within small AAAs
NP-delivered tPA achieves much slower clot lysis versus equivalent dose of exogenous tPA.
NP-released tPA attenuates proteolysis and limits elastic matrix loss versus exogenous tPA.
NPs with cationic surfaces show improved clot binding and slowed clot lysis versus anionic NPs.